SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,993 | +1.6% | 55 | 0.0% | 0.00% | – |
| Q4 2022 | $1,962 | – | 55 | – | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2020 | $5,000 | +400.0% | 224 | +833.3% | 0.00% | – |
| Q4 2019 | $1,000 | -95.7% | 24 | -96.6% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | 0.0% | 704 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $23,000 | +666.7% | 704 | +780.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 80 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 80 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -42.9% | 80 | -34.4% | 0.00% | -100.0% |
| Q2 2018 | $7,000 | 0.0% | 122 | -15.3% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | +40.0% | 144 | +21.0% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 119 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $5,000 | 0.0% | 119 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | +400.0% | 119 | +197.5% | 0.00% | – |
| Q1 2017 | $1,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |